Phio Pharmaceuticals (PHIO) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.87, -5.93% vs the prior close of $0.93.
- Volume 91.13K shares, 0.6x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
PHIO slides 5.9% to $0.87, a 6-month low. Closed at $0.87, -5.93% vs the prior close of $0.93. Day range $0.87–$0.94, opened at $0.94.
PHIO daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — PHIO slides 5.9% to $0.87, a 6-month low
- Closed at $0.87, -5.93% vs the prior close of $0.93. Day range $0.87–$0.94, opened at $0.94.
- Volume was 91.13K shares, 0.6x its 50-day average of 142.12K.
- Price is -16.7% vs its 50-day average ($1.05) and -20.9% vs its 200-day average ($1.10).
- 52-week range $0.81–$4.19; today's close sits at 2% of that range, 79.2% below the 52-week high.
Oct 15, 2026 — PHIO dips 2.5% to $0.93
- Closed at $0.93, -2.53% vs the prior close of $0.95. Day range $0.90–$0.98, opened at $0.90.
- Volume was 135.80K shares, 1.0x its 50-day average of 140.49K.
- Price is -11.7% vs its 50-day average ($1.05) and -16.0% vs its 200-day average ($1.10).
- 52-week range $0.81–$4.19; today's close sits at 3% of that range, 77.9% below the 52-week high.
Oct 14, 2026 — PHIO rises 1.6% to $0.95
- Closed at $0.95, +1.60% vs the prior close of $0.94. Day range $0.89–$0.95, opened at $0.91.
- Volume was 132.20K shares, 0.9x its 50-day average of 143.73K.
- Price is -9.7% vs its 50-day average ($1.05) and -13.9% vs its 200-day average ($1.10).
- 52-week range $0.81–$4.19; today's close sits at 4% of that range, 77.3% below the 52-week high.
Oct 13, 2026 — PHIO rises 1.4% to $0.94
- Closed at $0.94, +1.41% vs the prior close of $0.92. Day range $0.92–$0.96, opened at $0.96.
- Volume was 69.20K shares, 0.5x its 50-day average of 143.70K — lighter than usual.
- Price is -11.3% vs its 50-day average ($1.05) and -15.3% vs its 200-day average ($1.10).
- 52-week range $0.81–$4.19; today's close sits at 4% of that range, 77.7% below the 52-week high.
- SEC filings that day: 8-K.
Oct 12, 2026 — PHIO slides 5.8% to $0.92, a 1-month low
- Closed at $0.92, -5.82% vs the prior close of $0.98. Day range $0.91–$0.99, opened at $0.99.
- Volume was 45.50K shares, 0.3x its 50-day average of 144.70K — lighter than usual.
- Price is -12.7% vs its 50-day average ($1.06) and -16.5% vs its 200-day average ($1.10).
- 52-week range $0.81–$4.19; today's close sits at 3% of that range, 78.0% below the 52-week high.
Oct 9, 2026 — PHIO rises 0.6% to $0.98
- Closed at $0.98, +0.62% vs the prior close of $0.97. Day range $0.97–$1.00, opened at $0.97.
- Volume was 43.20K shares, 0.3x its 50-day average of 145.50K — lighter than usual.
- Price is -7.5% vs its 50-day average ($1.06) and -11.4% vs its 200-day average ($1.10).
- 52-week range $0.81–$4.19; today's close sits at 5% of that range, 76.6% below the 52-week high.
Oct 8, 2026 — PHIO dips 2.7% to $0.97, a 1-month low
- Closed at $0.97, -2.70% vs the prior close of $1.00. Day range $0.97–$0.99, opened at $0.97.
- Volume was 66.00K shares, 0.5x its 50-day average of 146.08K — lighter than usual.
- Price is -8.2% vs its 50-day average ($1.06) and -12.0% vs its 200-day average ($1.11).
- 52-week range $0.81–$4.19; today's close sits at 5% of that range, 76.8% below the 52-week high.
Oct 7, 2026 — PHIO rises 0.6% to $1.00, 3 up days in a row
- Closed at $1.00, +0.60% vs the prior close of $0.99. Day range $0.97–$1.02, opened at $0.99.
- Volume was 92.90K shares, 0.6x its 50-day average of 146.58K.
- Price is -5.6% vs its 50-day average ($1.06) and -9.6% vs its 200-day average ($1.11).
- 52-week range $0.81–$4.19; today's close sits at 6% of that range, 76.1% below the 52-week high.
- That makes 3 straight gains.
Oct 6, 2026 — PHIO rises 0.3% to $0.99
- Closed at $0.99, +0.30% vs the prior close of $0.99. Day range $0.97–$1.02, opened at $1.00.
- Volume was 131.80K shares, 0.9x its 50-day average of 145.66K.
- Price is -6.2% vs its 50-day average ($1.06) and -10.1% vs its 200-day average ($1.11).
- 52-week range $0.81–$4.19; today's close sits at 5% of that range, 76.3% below the 52-week high.
Oct 5, 2026 — PHIO rises 0.6% to $0.99
- Closed at $0.99, +0.61% vs the prior close of $0.99. Day range $0.98–$1.12, opened at $1.00.
- Volume was 202.60K shares, 1.4x its 50-day average of 143.31K.
- Price is -6.6% vs its 50-day average ($1.06) and -10.4% vs its 200-day average ($1.11).
- 52-week range $0.81–$4.19; today's close sits at 5% of that range, 76.3% below the 52-week high.
Oct 2, 2026 — PHIO dips 1.5% to $0.99, a 1-month low, 3 down days in a row
- Closed at $0.99, -1.50% vs the prior close of $1.00. Day range $0.98–$1.02, opened at $1.00.
- Volume was 54.20K shares, 0.4x its 50-day average of 144.40K — lighter than usual.
- Price is -7.2% vs its 50-day average ($1.06) and -11.0% vs its 200-day average ($1.11).
- 52-week range $0.81–$4.19; today's close sits at 5% of that range, 76.5% below the 52-week high.
- That makes 3 straight losses.
PHIO latest news & SEC filings
Every SEC filing by or about PHIO in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 30, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Plott Ronald Todd bought 5,000 shares at $1.03 (≈$5.15K) on Sep 28, 2026; now holds 37,000
- Plott Ronald Todd bought 5,000 shares at $1.04 (≈$5.20K) on Sep 29, 2026; now holds 42,000
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Carson Lisa Cabott received an award of 108,000 shares on Sep 28, 2026; now holds 189,112
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Bitterman Robert J received an award of 400,000 shares on Sep 28, 2026; now holds 764,871
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Plott Ronald Todd received an award of 17,000 shares on Sep 28, 2026; now holds 32,000
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 28, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Sep 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 5.07 — Reported shareholder vote results.
Sep 25, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Bradford Patricia A bought 6,500 shares at $1.01 (≈$6.58K) on Sep 24, 2026; now holds 64,151
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 23, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Bitterman Robert J bought 2,000 shares at $1.03 (≈$2.06K) on Sep 22, 2026; now holds 364,871
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 14, 2026 · Form ARS — Annual report to shareholders
Annual report to shareholders
Aug 14, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Aug 14, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$4.14M (prior year -$2.17M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.36 (prior year -$0.45) (loss narrowed vs Jun 30, 2025)
Things to know before you trade PHIO
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Mar 5, 2026, Nov 13, 2025. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.72% (largest 5.9%).
- Liquidity: about 103.41K shares (≈$90.08K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.87 vs a range of $0.81–$4.19 (2% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Ronald Todd Plott bought 5,000 shares on Sep 29, 2026.
- Latest filings: 8-K Oct 13, 2026; 8-K Sep 28, 2026; 8-K Sep 14, 2026.
- Share count: 11.62M shares outstanding (Aug 4, 2026), +102.9% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
PHIO market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.94 | 0.94 | 0.87 | 0.87 | 91.13K |
| Oct 15, 2026 | 0.90 | 0.98 | 0.90 | 0.93 | 135.80K |
| Oct 14, 2026 | 0.91 | 0.95 | 0.89 | 0.95 | 132.20K |
| Oct 13, 2026 | 0.96 | 0.96 | 0.92 | 0.94 | 69.20K |
| Oct 12, 2026 | 0.99 | 0.99 | 0.91 | 0.92 | 45.50K |
| Oct 9, 2026 | 0.97 | 1.00 | 0.97 | 0.98 | 43.20K |
| Oct 8, 2026 | 0.97 | 0.99 | 0.97 | 0.97 | 66.00K |
| Oct 7, 2026 | 0.99 | 1.02 | 0.97 | 1.00 | 92.90K |
| Oct 6, 2026 | 1.00 | 1.02 | 0.97 | 0.99 | 131.80K |
| Oct 5, 2026 | 1.00 | 1.12 | 0.98 | 0.99 | 202.60K |
| Oct 2, 2026 | 1.00 | 1.02 | 0.98 | 0.99 | 54.20K |
| Oct 1, 2026 | 1.05 | 1.05 | 1.00 | 1.00 | 50.10K |
| Sep 30, 2026 | 1.05 | 1.07 | 1.03 | 1.03 | 99.50K |
| Sep 29, 2026 | 1.02 | 1.05 | 1.00 | 1.03 | 80.60K |
| Sep 28, 2026 | 1.00 | 1.04 | 0.99 | 1.01 | 112.20K |
| Sep 25, 2026 | 1.03 | 1.05 | 0.99 | 1.01 | 238.50K |
| Sep 24, 2026 | 1.03 | 1.04 | 0.99 | 1.02 | 64.90K |
| Sep 23, 2026 | 1.02 | 1.03 | 1.00 | 1.02 | 75.20K |
| Sep 22, 2026 | 1.02 | 1.05 | 0.99 | 1.00 | 204.10K |
| Sep 21, 2026 | 1.04 | 1.05 | 1.00 | 1.01 | 78.50K |
About Phio Pharmaceuticals
Phio Pharmaceuticals (PHIO) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in KING OF PRUSSIA, PA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1533040.
PHIO board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Patricia A Bradford | Director | Sep 25, 2026 |
| Robert J Bitterman | Chairman, Pres. & CEO | Sep 29, 2026 |
| David H Deming | Director | Feb 6, 2026 |
| Jonathan E Freeman | Director | Feb 6, 2026 |
| Curtis Lockshin | Director | Feb 6, 2026 |
| Ronald Todd Plott | Director | Sep 30, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Robert J Bitterman | Chairman, Pres. & CEO | Sep 29, 2026 |
| Lisa Cabott Carson | Chief Financial Officer | Sep 29, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 29, 2026 | Ronald Todd Plott | Buy | 5,000 | $1.04 |
| Sep 29, 2026 | Ronald Todd Plott | Buy | 5,000 | $1.04 |
| Sep 29, 2026 | Ronald Todd Plott | Buy | 5,000 | $1.04 |
| Sep 29, 2026 | Ronald Todd Plott | Buy | 5,000 | $1.04 |
| Sep 28, 2026 | Ronald Todd Plott | Buy | 5,000 | $1.03 |
| Sep 28, 2026 | Ronald Todd Plott | Buy | 5,000 | $1.03 |
| Sep 28, 2026 | Ronald Todd Plott | Buy | 5,000 | $1.03 |
| Sep 28, 2026 | Ronald Todd Plott | Buy | 5,000 | $1.03 |
| Sep 24, 2026 | Patricia A Bradford | Buy | 6,500 | $1.01 |
| Sep 24, 2026 | Patricia A Bradford | Buy | 6,500 | $1.01 |
| Sep 24, 2026 | Patricia A Bradford | Buy | 6,500 | $1.01 |
| Sep 24, 2026 | Patricia A Bradford | Buy | 6,500 | $1.01 |
| Sep 22, 2026 | Robert J Bitterman | Buy | 2,000 | $1.03 |
| Sep 22, 2026 | Robert J Bitterman | Buy | 2,000 | $1.03 |
| Sep 22, 2026 | Robert J Bitterman | Buy | 2,000 | $1.03 |
PHIO financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-8.70M | — | $-7.98M |
| Dec 31, 2024 | — | $-7.15M | -9.08 | $-7.11M |
| Dec 31, 2023 | — | $-10.83M | -46.76 | $-10.75M |
| Dec 31, 2022 | — | $-11.48M | -10.10 | $-12.13M |
| Dec 31, 2021 | — | $-13.29M | -12.43 | $-11.86M |
Latest balance sheet: total assets $14.31M, total liabilities $1.71M, cash $13.00M (as of Jun 30, 2026).
PHIO earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $1.06 |
| May 7, 2026 | 8-K Item 2.02 (results) | $1.14 |
| Mar 5, 2026 | 8-K Item 2.02 (results) | $1.17 |
| Nov 13, 2025 | 8-K Item 2.02 (results) | $1.43 |
| Aug 14, 2025 | 8-K Item 2.02 (results) | $2.19 |
| May 15, 2025 | 8-K Item 2.02 (results) | $1.78 |
| Mar 31, 2025 | 8-K Item 2.02 (results) | $1.30 |
| Nov 14, 2024 | 8-K Item 2.02 (results) | $2.23 |
| Aug 14, 2024 | 8-K Item 2.02 (results) | — |
| May 9, 2024 | 8-K Item 2.02 (results) | — |
| Apr 2, 2024 | 8-K Item 2.02 (results) | — |
| Nov 9, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on PHIO
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.